Opinions about systemic therapy for after successful resection

For cases with synchronous hepatic disease this might be viewed as adjuvant therapy.

For cases with metachronous hepatic disease this might be viewed as therapy to reduce the risk of further recurrence (essentially playing the same role as adjuvant therapy).